EIDX - Eidos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $0.11. This is a potential upside of $0.11 (0%) from yesterday's end of day stock price of $0.

Eidos Therapeutics's activity chart (see below) currently has 20 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 94.4 days.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 16-Jul-2018.

Best performing analysts who are covering EIDX - Eidos Therapeutics:

Tyler Van Buren Anupam Rama Mani Foroohar Joel Beatty Gena Wang

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$129

$6.79 (5.56%)

$73.26

4 years 11 months 17 days ago
(29-Dec-2020)

2/2 (100%)

$4.39 (3.52%)

1

Hold

$73.26

$-48.95 (-40.05%)

$80

5 years 2 months 11 days ago
(05-Oct-2020)

3/3 (100%)

$-0.25 (-0.34%)

128

Hold

$59

$-63.21 (-51.72%)

$59

5 years 2 months 11 days ago
(05-Oct-2020)

2/3 (66.67%)

$-14.51 (-19.74%)

84

Sell

$45

5 years 7 months 5 days ago
(11-May-2020)

1/2 (50%)

$-6 (-11.76%)

22

Hold

$29

6 years 9 months 19 days ago
(27-Feb-2019)

2/2 (100%)

$16.9 (139.67%)

237

Show more analysts

Please expand the browser size to see the chart

What is EIDX (Eidos Therapeutics) average time for price targets to be met?

On average it took 94.4 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on EIDX (Eidos Therapeutics) with a proven track record?

TYLER VAN BUREN

Which analyst has the current lower performing score on EIDX (Eidos Therapeutics) with a proven track record?

GENA WANG

Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?

Tyler Van Buren works at TD COWEN and has 0 price targets and 2 ratings on EIDX

Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?

Joel Beatty with highest potential upside - $6.79

Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?

Mani Foroohar with lowest potential downside - -$63.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?